The 10-second takeaway
For the quarter ended June 30 (Q2), VCA Antech met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded. GAAP earnings per share grew significantly.
Margins expanded across the board.
VCA Antech reported revenue of $465.3 million. The 11 analysts polled by S&P Capital IQ expected revenue of $469.8 million on the same basis. GAAP reported sales were 6.1% higher than the prior-year quarter's $438.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
EPS came in at $0.46. The seven earnings estimates compiled by S&P Capital IQ predicted $0.45 per share. GAAP EPS of $0.46 for Q2 were 18% higher than the prior-year quarter's $0.39 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the quarter, gross margin was 24.6%, 160 basis points better than the prior-year quarter. Operating margin was 16.2%, 200 basis points better than the prior-year quarter. Net margin was 9.0%, 120 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $465.2 million. On the bottom line, the average EPS estimate is $0.43.
Next year's average estimate for revenue is $1.82 billion. The average EPS estimate is $1.60.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 232 members out of 246 rating the stock outperform, and 14 members rating it underperform. Among 93 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 87 give VCA Antech a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on VCA Antech is outperform, with an average price target of $28.22.
Is VCA Antech the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add VCA Antech to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month. The Motley Fool recommends VCA Antech. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.